Drug Profile
NT 100
Alternative Names: NT-100Latest Information Update: 25 Aug 2016
Price :
$50
*
At a glance
- Originator Nora Therapeutics
- Class Chemoprotectants; Granulocyte colony-stimulating factors; Infertility therapies; Neuroprotectants
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase II Female infertility
Most Recent Events
- 25 Aug 2016 Phase-II development is ongoing in United Kingdom
- 06 Jun 2016 Nora Therapeutics completes the phase III RESPONSE trial for Female infertility in United Kingdom (EudraCT2014-000084-40)
- 01 Sep 2015 Nora Therapeutics completes a phase II follow-up trial in Female infertility in USA (NCT01978561)